Clear Cell Carcinoma in Tuberous Sclerosis Complex: Case Report and Review of the Literature
Main Article Content
Abstract
BACKGROUND: Tuberous sclerosis is a rare autosomal dominant genetic disorder caused by a mutation in either the TSC1 or TSC2 genes, with a global incidence ranging from 1 in every 6,000 to 10,000 newborns. Its pathophysiological mechanism is not fully understood; however, it is known that the TSC1 and TSC2 genes encode the proteins hamartin and tuberin, which form a complex that regulates mTOR, considered a key pathway in controlling cell growth. Clinical manifestations include cutaneous, neurological, cardiac, and renal abnormalities, among which the development of benign and/or malignant renal tumors stands out—particularly angiomyolipoma or clear cell renal carcinoma.
CLINICAL CASE: A 31-year-old male patient presented to the emergency department with generalized abdominal pain (VAS 8/10) radiating to the right iliac fossa, unresponsive to analgesics, and accompanied by changes in bowel habits, fever, and a 20-kilogram weight loss over one month. A diagnostic work-up was performed, documenting a right renal tumor.
CONCLUSIONS: Tuberous Sclerosis Complex (TSC) is known to predispose individuals to the formation of benign tumors in any organ of the body, with corresponding clinical consequences. However, the development of clear cell renal carcinoma is a rare finding, as most renal tumors in these patients tend to be angiomyolipomas, which are benign in the vast majority of cases.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Ruiz Villaverde, R., Melguizo, B., Cruz, M., Sánchez, M., & Sintes, R. N. (2002). Esclerosis tuberosa. Enfermedad de Pringle Bourneville. In Actas Dermosifiliogr (Vol. 93, Issue 1).
II. Uysal, S. P., & Şahin, M. (2020). Tuberous sclerosis: A review of the past, present, and future. In Turkish Journal of Medical Sciences (Vol. 50, Issue SI-2, pp. 1665–1676). Turkiye Klinikleri. https://doi.org/10.3906/sag-2002-133
III. Lam, H. C., Siroky, B. J., & Henske, E. P. (2018). Renal disease in tuberous sclerosis complex: pathogenesis and therapy. In Nature Reviews Nephrology (Vol. 14, Issue 11, pp. 704–716). Nature Publishing Group.
https://doi.org/10.1038/s41581-018-0059-6.
IV. Huang, J., & Manning, B. D. (2008). The TSC1–TSC2 complex: a molecular switchboard controlling cell growth. Biochemical Journal, 412(2), 179–190.
https://doi.org/10.1042/BJ20080281
V. Luo, C., Ye, W. R., Shi, W., Yin, P., Chen, C., He, Y. B., Chen, M. F., Zu, X. bin, & Cai, Y. (2022). Perfect match: mTOR inhibitors and tuberous sclerosis complex. In Orphanet Journal of Rare Diseases (Vol. 17, Issue 1). BioMed Central Ltd. https://doi.org/10.1186/s13023-022-02266-0
VI. Napolioni, V., & Curatolo, P. (2008). Genetics and Molecular Biology of Tuberous Sclerosis Complex. In Current Genomics (Vol. 9).
VII. Henske, E. P., Cornejo, K. M., & Wu, C. L. (2021). Renal cell carcinoma in tuberous sclerosis complex. In Genes (Vol. 12, Issue 10). MDPI.
https://doi.org/10.3390/genes12101585
VIII. European Chromosome 16 Tuberous Sclerosis Consortium (1993). (1993). Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell, 75(7), 1305–1315. https://doi.org/10.1016/0092-8674(93)90618-Z
IX. Sampson, J. R., Scahill, S. J., Stephensont, J. B. P., Mann, L., & Connor, J. M. (1989). Genetic aspects of tuberous sclerosis in the west of Scotland. In Journal of Medical Genetics (Vol. 26).
X. Bjornsson, J., Short, M. P., Kwiatkowski, D. J., & Hensket, E. P. (1996). Tuberous Sclerosis-Associated Renal Cell Carcinoma Clinical, Pathological, and Genetic Features. In American journal of Pathology (Vol. 149, Issue 4).
XI. Northrup, H., Koenig, M. K., Pearson, D. A., & Au, K. S. (1993). Tuberous Sclerosis Complex.
XII. Jones, A. C., Daniells, C. E., Snell, R. G., Tachataki, M., Idziaszczyk, S. A., Krawczak, M., Sampson, J. R., & Cheadle, J. P. (1997). Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis. In Human Molecular Genetics (Vol. 6, Issue 12). Oxford University Press.
XIII. Eble JN. (2004). Pathology and genetics of tumours of the urinary system and male genital organs (Eble JN, Sauter G, Epstein JI, & Sesterhenn IA, Eds.; 3rd ed., Vol. 7). IARC Press ; Oxford University Press (distributor). https://publications.iarc.who.int/Book-And-Report-Series/Who-Classification-Of-Tumours/Pathology-And-Genetics-Of-Tumours-Of-The-Urinary-System-And-Male-Genital-Organs-2004
XIV. Rakowski, S. K., Winterkorn, E. B., Paul, E., Steele, D. J. R., Halpern, E. F., & Thiele, E. A. (2006). Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors. Kidney International, 70(10), 1777–1782.
https://doi.org/10.1038/sj.ki.5001853
XV. Henske, E. (2004). The Genetic Basis of Kidney Cancer: Why is Tuberous Sclerosis Complex Often Overlooked? Current Molecular Medicine, 4(8),
–831. https://doi.org/10.2174/1566524043359610
XVI. Gupta, S., Stanton, M. L., Reynolds, J. P., Whaley, R. D., Herrera-Hernandez, L., Jimenez, R. E., & Cheville, J. C. (2022). Lessons from histopathologic examination of nephrectomy specimens in patients with tuberous sclerosis complex: cysts, angiomyolipomas, and renal cell carcinoma. Human Pathology, 129, 123–139.
https://doi.org/10.1016/j.humpath.2022.09.001
XVII. Adeniran, A. J., Shuch, B., & Humphrey, P. A. (2024). Sarcomatoid and Rhabdoid Renal Cell Carcinoma. American Journal of Surgical Pathology, 48(7), e65–e88.
https://doi.org/10.1097/PAS.0000000000002233
XVIII. Shah, J. N., Gandhi, D., Prasad, S. R., Sandhu, P. K., Banker, H., Molina, R., Khan, M. S., Garg, T., & Katabathina, V. S. (2023). Wunderlich Syndrome: Comprehensive Review of Diagnosis and Management. In Radiographics (Vol. 43, Issue 6). Radiological Society of North America Inc. https://doi.org/10.1148/rg.220172.
XIX. Liu, C., Lele, S. M., Goodenberger, M. H., Reiser, G. M., Christiansen, A. J., & Padussis, J. C. (2024). Malignant tumors in tuberous sclerosis complex: a case report and review of the literature. BMC Medical Genomics, 17(1).
https://doi.org/10.1186/s12920-024-01913-8
XX. Conte, E., Boccanegra, B., Dinoi, G., Pusch, M., de Luca, A., Liantonio, A., & Imbrici, P. (2024). Therapeutic Approaches to Tuberous Sclerosis Complex: From Available Therapies to Promising Drug Targets. In. Biomolecules (Vol. 14, Issue 9). Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/biom14091190